CONSIDERATIONS TO KNOW ABOUT AZELAPRAG SMALL MOLECULE

In December, BioAge announced a multi-yr investigation collaboration with Novartis to detect and validate novel therapeutic targets within the intersection of aging biology and physical exercise, combining BioAge's longitudinal human growing older datasets with Novartis abilities in work out biology.Apelin receptor agonists are being pursued for hi